含有安波特素B的疏水性二元混合物作为皮肤莱什曼病治疗的脂性溶液
Luc Augis1, Cảnh Hưng Nguyễn2, Cécile Ciseran1
1Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, 91400 Orsay, France.
International journal of pharmaceutics
|July 21, 2024
概括
研究人员开发了一种用于皮肤莱什曼病的局部安福特素B (AmB) 溶液. 使用盐和甘油衍生物的有希望的配方显示出良好的安全性和皮肤保留性,提供了潜在的新治疗方法.
科学领域:
- 制药科学 制药科学
- 皮肤病学 皮肤病学
- 材料科学 材料科学 材料科学
背景情况:
- 皮肤莱什曼病治疗需要比目前的治疗方法更安全的替代方案.
- 氨酸B (AmB) 是一种强效的抗真菌剂,具有治疗莱什曼病的潜力.
- 深度浸泡溶剂 (DES) 为药物配方提供独特的特性.
研究的目的:
- 开发一种用于皮肤莱什曼病的局部安二乙 (AmB) 配方.
- 为了探索深层水解溶剂 (DESs) 作为AmB的疏水辅助剂.
- 评估开发的AmB配方的安全性,有效性和皮肤透性.
主要方法:
- 选各种深溶解剂 (DES) 混合物,包括四级盐.
- 使用热分析和X射线散射来描述配方.
- 在体外和体外研究包括组织学评估,AmB溶解,圆形二元化,刺激测试和皮肤透测试.
主要成果:
- 基于四级盐的DES混合物显示出AmB配方的潜力.
- 最佳配方,含有三 () 和1-oleoyl-rac-glycerol,呈现出类似海绵的纳米结构.
- AmB有效地溶解,保持在单体形式,并证明了可接受的体外安全性.
- 活体研究证实AmB在皮肤层内保留,没有通过皮肤传递.
结论:
- 通过使用DES组件成功开发了一种新的局部AmB配方.
- 该配方表现出有利的安全性概况和有效的皮肤保留.
- 这种AmB配方有望成为一种更安全,更有效的治疗皮肤莱什曼病的方法.
关键词:
氨基氨酸B (Amphotericin B) 是一种氨基氨酸.皮肤上的莱什曼病.深层欧性溶剂 深层欧性溶剂弗朗茨的扩散细胞脂友性溶液是一种溶液.低过渡温度混合物混合物在MTT测试中使用MTT测试.更多相关视频
12:22A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line
Published on: December 30, 2012
22.4K
12:02An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity
Published on: November 2, 2016
12.1K
相关概念视频
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...